Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

Delayed Quote. Delayed Nasdaq - 04/23 04:00:01 pm
303.08 USD   -2.76%
4h ago REGENERON PHARMACEUTICALS : Patent Issued for MiRNA-Regulated Differentiati..
2d ago Studies find new drugs greatly lower cholesterol
04/16 NASDAQ 100 MOVERS : Lltc, yhoo
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Regeneron Pharmaceuticals Inc : Regeneron Pharmaceuticals Assigned Patent

12/31/2013 | 03:06am US/Eastern
Recommend:
0

By Targeted News Service

ALEXANDRIA, Va., Dec. 31 -- Regeneron Pharmaceuticals, Tarrytown, N.Y., has been assigned a patent (8,613,927) developed by five co-inventors for a "high affinity human antibodies to human nerve growth factor." The co-inventors are Lynn MacDonald, White Plains, N.Y., Richard Torres, New York, Marc R. Morra, Beacon Falls, Conn., Joel H. Martin, Putnam Valley, N.Y., and Joel C. Reinhardt, Mount Kisco, N.Y.

The patent application was filed on Feb. 28, 2012 (13/406,734). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=3&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=141&f=G&l=50&co1=AND&d=PTXT&s1=20131224.PD.&s2=%28NY.ASST.%29&OS=ISD/12/24/2013+AND+AS/NY&RS=ISD/12/24/2013+AND+AS/NY

Written by Sudarshan Harpal; edited by Jaya Anand.

SH1231JA1231-963857

© Targeted News Service, Acquiremedia 2014
Recommend :
0
React to this article
Latest news on REGENERON PHARMACEUTICALS
4h ago REGENERON PHARMACEUTICALS : Patent Issued for MiRNA-Regulated Differentiation-De..
2d ago Studies find new drugs greatly lower cholesterol
04/16 NASDAQ 100 MOVERS : Lltc, yhoo
04/14 REGENERON PHARMACEUTICALS : Yale University Assigned Patent
04/11 REGENERON PHARMACEUTICALS : to Report First Quarter 2014 Financial and Operating..
04/10 REGENERON PHARMACEUTICALS : Sanofi : and Regeneron Report Positive Results With ..
04/10 REGENERON PHARMACEUTICALS : Announces Initiative for STEM Education in Hudson Va..
04/09 REGENERON PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
04/09 NASDAQ 100 MOVERS : Isrg, regn
04/08 REGENERON PHARMACEUTICALS : Introduces Initiative for STEM Education in Hudson V..
Advertisement
Chart
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Income Statement Evolution
Regeneron Pharmaceuticals  : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF